Tilray Inc (TLRY) - Total Liabilities

Latest as of May 2026: $733.14 Million USD

Based on the latest financial reports, Tilray Inc (TLRY) has total liabilities worth $733.14 Million USD as of May 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore TLRY long-term investment intensity to see how much of total assets are deployed in long-term investments.

Tilray Inc - Total Liabilities Trend (2012–2026)

This chart illustrates how Tilray Inc's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see total assets of Tilray Inc.

Tilray Inc Competitors by Total Liabilities

The table below lists competitors of Tilray Inc ranked by their total liabilities.

Company Country Total Liabilities
Elior SCA
PA:ELIOR
France €2.91 Billion
Regenxbio Inc
NASDAQ:RGNX
USA $314.85 Million
Nextdoor Holdings Inc
NYSE:KIND
USA $60.82 Million
Zaptec AS
OL:ZAP
Norway Nkr425.90 Million
Matrix Concepts Holdings Bhd
KLSE:5236
Malaysia RM1.18 Billion
Beyond, Inc.
NASDAQ:BYON
USA $226.87 Million
Stendörren Fastigheter AB (publ)
ST:STEF-B
Sweden Skr11.19 Billion
Kforce Inc.
NASDAQ:KFRC
USA $242.03 Million

Liability Composition Analysis (2012–2026)

This chart breaks down Tilray Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Tilray Inc balance sheet independence to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 2.21 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.45 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.31 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Tilray Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Tilray Inc (2012–2026)

The table below shows the annual total liabilities of Tilray Inc from 2012 to 2026.

Year Total Liabilities Change
2026-05-31 $733.14 Million -14.80%
2025-05-31 $860.49 Million -29.21%
2024-05-31 $1.22 Billion -15.48%
2023-05-31 $1.44 Billion +13.15%
2022-05-31 $1.27 Billion -18.52%
2021-05-31 $1.56 Billion +163.37%
2020-05-31 $592.35 Million +28.03%
2019-05-31 $462.67 Million +699.76%
2018-05-31 $57.85 Million +39.42%
2017-05-31 $41.49 Million +5464.90%
2016-05-31 $745.62K +21.85%
2015-05-31 $611.91K +6283.40%
2014-05-31 $9.59K -3.30%
2013-05-31 $9.91K -11.44%
2012-05-31 $11.19K --

About Tilray Inc

NASDAQ:TLRY USA Drug Manufacturers - Specialty & Generic
Market Cap
$542.07 Million
Market Cap Rank
#11901 Global
#3011 in USA
Share Price
$3.94
Change (1 day)
+0.25%
52-Week Range
$0.78 - $13.94
All Time High
$214.06
About

Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and… Read more